title: Cannabis cue-elicited craving and the reward neurocircuitry.
abstract: Cue-elicited craving or the intense desire to consume a substance following exposure to a conditioned drug cue is one of the primary behavioral symptoms of substance use disorders (SUDs). While the concept of cue-elicited craving is well characterized in alcohol and other substances of abuse, only recently has it been described in cannabis. A review of the extant literature has established that cue-elicited craving is a powerful reinforcer that contributes to drug-seeking for cannabis. Further, emergent research has begun to identify the neurobiological systems and neural mechanisms associated with this behavior. What research shows is that while theories of THC's effects on the dopaminergic-reward system remain divergent, cannabis cues elicit neural activation in the brain's reward network.
authors.affiliation: Center for BrainHealth, School of Behavioral and Brain Sciences, University of Texas at Dallas, Dallas, TX 75235, USA. francesca.filbey@utdallas.edu
authors.forename: Francesca M
authors.initials: FM
authors.lastname: Filbey
authors.forename: Samuel J
authors.initials: SJ
authors.lastname: DeWitt
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects*; D002186:Cannabinoids / Q000494:pharmacology*; D002188:Cannabis; D009042:Motivation / Q000187:drug effects*; D009434:Neural Pathways / Q000187:drug effects; D012201:Reward
chemical_list: D002186:Cannabinoids
references.citation: Drug Alcohol Depend. 2006 Oct 15;85(1):75-82
references.pmid: 16701963
references.citation: Neurobiol Learn Mem. 2002 Nov;78(3):610-24
references.pmid: 12559839
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8384-8
references.pmid: 12060781
references.citation: Neuropsychopharmacology. 2007 Feb;32(2):298-308
references.pmid: 16760924
references.citation: Br J Pharmacol. 2010 Jun;160(3):724-35
references.pmid: 20590575
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Neuropsychopharmacology. 2010 Mar;35(4):967-75
references.pmid: 20010552
references.citation: J Neurochem. 2006 Jul;98(2):408-19
references.pmid: 16805835
references.citation: Psychopharmacology (Berl). 2011 Nov;218(1):49-58
references.pmid: 21710170
references.citation: Neuroreport. 2006 Oct 23;17(15):1629-32
references.pmid: 17001282
references.citation: J Neurosci. 2004 Jan 7;24(1):53-62
references.pmid: 14715937
references.citation: Pharmacol Res. 2007 Nov;56(5):393-405
references.pmid: 17936009
references.citation: J Psychoactive Drugs. 2009 Jun;41(2):105-12
references.pmid: 19705672
references.citation: Brain Res Bull. 2003 Jul 15;61(2):125-8
references.pmid: 12831997
references.citation: Eur J Pharmacol. 1998 Jan 2;341(1):39-44
references.pmid: 9489854
references.citation: J Neurophysiol. 2001 Jan;85(1):72-83
references.pmid: 11152707
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
references.pmid: 18640920
references.citation: Psychopharmacology (Berl). 2009 Apr;203(3):511-7
references.pmid: 19002671
references.citation: Br J Pharmacol. 2004 Sep;143(2):227-34
references.pmid: 15313883
references.citation: Br J Pharmacol. 1999 Sep;128(1):21-6
references.pmid: 10498830
references.citation: Annu Rev Neurosci. 2006;29:565-98
references.pmid: 16776597
references.citation: J Abnorm Psychol. 1988 May;97(2):118-32
references.pmid: 3290303
references.citation: Eur J Neurosci. 2008 Feb;27(4):976-83
references.pmid: 18333968
references.citation: Pharmacol Biochem Behav. 2005 Jun;81(2):263-84
references.pmid: 15936806
references.citation: Addict Biol. 2008 Jun;13(2):188-95
references.pmid: 18279497
references.citation: Exp Clin Psychopharmacol. 2002 Feb;10(1):47-53
references.pmid: 11871362
references.citation: Brain Res. 1988 Jun 7;451(1-2):59-68
references.pmid: 2855215
references.citation: Alcohol Res Health. 1999;23(3):187-96
references.pmid: 10890814
references.citation: Neuropsychopharmacology. 2009 Feb;34(3):759-66
references.pmid: 18754005
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13016-21
references.pmid: 19651613
references.citation: Neuroreport. 1997 Feb 10;8(3):649-52
references.pmid: 9106740
references.citation: J Physiol. 1992 May;450:455-68
references.pmid: 1331427
references.citation: Psychopharmacology (Berl). 1990;102(2):156-62
references.pmid: 2177204
references.citation: Nat Neurosci. 2000 Nov;3(11):1073-4
references.pmid: 11036260
references.citation: Exp Clin Psychopharmacol. 2011 Jun;19(3):224-30
references.pmid: 21480734
references.citation: Addiction. 2008 Oct;103(10):1678-86
references.pmid: 18705688
references.citation: Psychol Addict Behav. 2008 Dec;22(4):582-6
references.pmid: 19071985
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Jpn J Pharmacol. 2000 Nov;84(3):229-36
references.pmid: 11138722
references.citation: Nature. 1990 Aug 9;346(6284):561-4
references.pmid: 2165569
references.citation: Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S97-S107
references.pmid: 18372102
references.citation: Am J Psychiatry. 2005 Aug;162(8):1403-13
references.pmid: 16055761
references.citation: Psychopharmacology (Berl). 2000 Jul;151(1):25-30
references.pmid: 10958113